Bracco Company Profile

What is the competitive landscape for BRACCO, and what generic alternatives to BRACCO drugs are available?

BRACCO has forty approved drugs.

There are three US patents protecting BRACCO drugs.

There are thirty-seven patent family members on BRACCO drugs in twelve countries and seventy-four supplementary protection certificates in eight countries.

Summary for Bracco

International Patents:	37
US Patents:	3
Tradenames:	64
Ingredients:	32
NDAs:	40

Drugs and US Patents for Bracco

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bracco	READI-CAT 2	barium sulfate	SUSPENSION;ORAL	208143-001	Jan 15, 2016		RX	Yes	Yes
Bracco	E-Z-HD	barium sulfate	FOR SUSPENSION;ORAL	208036-001	Jan 11, 2016		RX	Yes	Yes
Bracco	RENOGRAFIN-60	diatrizoate meglumine; diatrizoate sodium	INJECTABLE;INJECTION	010040-006	Approved Prior to Jan 1, 1982		DISCN	No	No
Bracco	ISOVUE-M 200	iopamidol	INJECTABLE;INJECTION	018735-001	Dec 31, 1985	AP1	RX	Yes	Yes
Bracco	TESULOID	technetium tc-99m sulfur colloid kit	SOLUTION;INJECTION, ORAL	016923-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Bracco	LIQUID E-Z-PAQUE	barium sulfate	SUSPENSION;ORAL	208143-003	Mar 1, 2017		RX	Yes	Yes

Expired US Patents for Bracco

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bracco	ISOVUE-300	iopamidol	INJECTABLE;INJECTION	018735-002	Dec 31, 1985	4,001,323
Bracco	ISOVUE-200	iopamidol	INJECTABLE;INJECTION	020327-001	Oct 12, 1994	4,001,323
Bracco	KINEVAC	sincalide	POWDER;INTRAVENOUS	017697-001	Approved Prior to Jan 1, 1982	3,839,315
Bracco	CHOLOVUE	iodoxamate meglumine	INJECTABLE;INJECTION	018076-001	Approved Prior to Jan 1, 1982	3,654,272
Bracco	LUMASON	sulfur hexafluoride lipid-type a microspheres	FOR SUSPENSION;INTRAVENOUS	203684-001	Oct 15, 2014	5,686,060
Bracco	PROHANCE	gadoteridol	INJECTABLE;INJECTION	020131-001	Nov 16, 1992	6,143,274

International Patents for Bracco Drugs

Country	Patent Number	Estimated Expiration
Mexico	2020012604
South Korea	102626600
European Patent Office	3969065
South Korea	20220008277
Australia	2020274620
Australia	2020276679

Supplementary Protection Certificates for Bracco Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1912999	1490062-5	Sweden		PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
2822954	18C1035	France		PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625
1499331	SPC/GB13/034	United Kingdom		PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313
2666774	CR 2020 00037	Denmark		PRODUCT NAME: RELEBACTAM, OPTIONALLY IN THE FORM OF THE MONOHYDRATE, IMIPENEM AND CILASTATIN, OPTIONALLY IN THE FORM OF THE SODIUM SALT; REG. NO/DATE: EU/1/19/1420 20200217
2932970	18C1043	France		PRODUCT NAME: UNE COMBINAISON COMPRENANT DU DOLUTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI,EN PARTICULIER LE SEL DE SODIUM DU DOLUTEGRAVIR,ET DE LA RILPIVIRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI,EN PARTICULIER LE CHLORHYDRATE DE RILPIVIRINE; REGISTRATION NO/DATE: EU/1/18/1282 20180518
1948158	16C0018	France		PRODUCT NAME: SACUBITRIL/VALSARTAN,SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN,C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL) PROPIONATE-(S)-3'-METHYL-2'-(PENTANOY(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE)DE TRISODIUM HEMIPENTAHYDRATE; REGISTRATION NO/DATE: EU/1/15/1058 20151123

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Bracco